Although only one mouse showed complete tumor rejection, rechallenge with both wild-type EMT6 and EMT6-HER2 cells, in opposing flanks, resulted in no tumor growth on either side, indicating the development of immunological memory not restricted to the antigenicity of HER2 (Fig. 3D). Here, ERBB2 is linked to neoplasm.